Order Article Reprints

Dumlu R, Çiçek Y, Kapmaz M, Derin O, Akalın H, Önal U, Özdemir E, Ataman Hatipoğlu Ç, Tuncer Ertem G, Şener A, et al. Switching to Long-Acting Cabotegravir and Rilpivirine in Turkey: Perspectives from People Living with HIV in a Setting of Increasing HIV Incidence. Medicina. 2025; 61(8):1373. https://doi.org/10.3390/medicina61081373

Dumlu, Rıdvan, Yeliz Çiçek, Mahir Kapmaz, Okan Derin, Halis Akalın, Uğur Önal, Egemen Özdemir, Çiğdem Ataman Hatipoğlu, Günay Tuncer Ertem, Alper Şener, and et al. 2025. "Switching to Long-Acting Cabotegravir and Rilpivirine in Turkey: Perspectives from People Living with HIV in a Setting of Increasing HIV Incidence" Medicina 61, no. 8: 1373. https://doi.org/10.3390/medicina61081373

Dumlu, R., Çiçek, Y., Kapmaz, M., Derin, O., Akalın, H., Önal, U., Özdemir, E., Ataman Hatipoğlu, Ç., Tuncer Ertem, G., Şener, A., Akgül, L., Çağlar, Y., Ecer, D. T., Çelen, M. K., Oğuz, N. B., Yıldırım, F., Borcak, D., Şenoğlu, S., Arslan, E., ... Mert, A. (2025). Switching to Long-Acting Cabotegravir and Rilpivirine in Turkey: Perspectives from People Living with HIV in a Setting of Increasing HIV Incidence. Medicina, 61(8), 1373. https://doi.org/10.3390/medicina61081373